107 related articles for article (PubMed ID: 8305130)
1. Delayed hypersensitivity, immune deviation, antigen processing and T-cell subset selection in syphilis pathogenesis and vaccine design.
Sell S; Hsu PL
Immunol Today; 1993 Dec; 14(12):576-82. PubMed ID: 8305130
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.
Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y
Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700
[TBL] [Abstract][Full Text] [Related]
3. [Role of thermolabile antigenic component of Treponema pallidum in inducing skin reaction for delayed hypersensitivity].
Podwińska J
Przegl Dermatol; 1985; 72(2):129-31. PubMed ID: 3901126
[No Abstract] [Full Text] [Related]
4. Progress towards an effective syphilis vaccine: the past, present and future.
Cullen PA; Cameron CE
Expert Rev Vaccines; 2006 Feb; 5(1):67-80. PubMed ID: 16451109
[TBL] [Abstract][Full Text] [Related]
5. Investigation of syphilis immunology and Treponema pallidum subsp. pallidum biology to improve clinical management and design a broadly protective vaccine: study protocol.
Osias E; Hung P; Giacani L; Stafylis C; Konda KA; Vargas SK; Reyes-Díaz EM; Comulada WS; Haake DA; Haynes AM; Caceres CF; Klausner JD
BMC Infect Dis; 2020 Jun; 20(1):444. PubMed ID: 32576149
[TBL] [Abstract][Full Text] [Related]
6. The role of protein component of T. pallidum in inducing skin reaction for delayed hypersensitivity.
Podwińska J
Arch Immunol Ther Exp (Warsz); 1983; 31(6):887-93. PubMed ID: 6378135
[TBL] [Abstract][Full Text] [Related]
7. Delayed-type hypersensitivity response in mice to Treponema pallidum.
Klein JR; Monjan AA
Immunol Commun; 1983; 12(1):25-30. PubMed ID: 6352464
[TBL] [Abstract][Full Text] [Related]
8. Immunization of rabbits with recombinant Treponema pallidum surface antigen 4D alters the course of experimental syphilis.
Borenstein LA; Radolf JD; Fehniger TE; Blanco DR; Miller JN; Lovett MA
J Immunol; 1988 Apr; 140(7):2415-21. PubMed ID: 2450921
[TBL] [Abstract][Full Text] [Related]
9. An In Silico Identification of Common Putative Vaccine Candidates against Treponema pallidum: A Reverse Vaccinology and Subtractive Genomics Based Approach.
Kumar Jaiswal A; Tiwari S; Jamal SB; Barh D; Azevedo V; Soares SC
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216574
[TBL] [Abstract][Full Text] [Related]
10. Effect of route of infection with Treponema pallidum. In vitro cellular response to treponemal antigens.
Maret SM; Rauchbach AS; Folds JD
Arch Pathol Lab Med; 1982 Sep; 106(9):436-9. PubMed ID: 7052010
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2.
Zhao F; Wu Y; Zhang X; Yu J; Gu W; Liu S; Zeng T; Zhang Y; Wang S
Hum Vaccin; 2011 Oct; 7(10):1083-9. PubMed ID: 21941092
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional and immunological analysis of the putative outer membrane protein and vaccine candidate TprL of Treponema pallidum.
Haynes AM; Fernandez M; Romeis E; Mitjà O; Konda KA; Vargas SK; Eguiluz M; Caceres CF; Klausner JD; Giacani L
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008812. PubMed ID: 33497377
[TBL] [Abstract][Full Text] [Related]
13. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.
Lithgow KV; Hof R; Wetherell C; Phillips D; Houston S; Cameron CE
Nat Commun; 2017 Feb; 8():14273. PubMed ID: 28145405
[TBL] [Abstract][Full Text] [Related]
14. [Attempts at developing a syphilis vaccine (author's transl)].
Metzger M
Dermatol Monatsschr; 1979 Apr; 165(4):257-63. PubMed ID: 378724
[TBL] [Abstract][Full Text] [Related]
15. Humoral immune response in human syphilis to polypeptides of Treponema pallidum.
Hanff PA; Fehniger TE; Miller JN; Lovett MA
J Immunol; 1982 Sep; 129(3):1287-91. PubMed ID: 7050242
[TBL] [Abstract][Full Text] [Related]
16. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
[TBL] [Abstract][Full Text] [Related]
17. Advances in the development of bacterial vector technology.
Kochi SK; Killeen KP; Ryan US
Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
[TBL] [Abstract][Full Text] [Related]
18. Immunological spectra in chronic infectious diseases.
Turk JL
Boll Ist Sieroter Milan; 1974; 53(1):suppl:208-12. PubMed ID: 4604571
[No Abstract] [Full Text] [Related]
19. Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92.
Cameron CE; Lukehart SA; Castro C; Molini B; Godornes C; Van Voorhis WC
J Infect Dis; 2000 Apr; 181(4):1401-13. PubMed ID: 10762571
[TBL] [Abstract][Full Text] [Related]
20. Effect of pretreatment with Mycobacterium bovis (strain BCG) and immune syphilitic serum on rabbit resistance to Treponema pallidum.
Graves SR; Johnson RC
Infect Immun; 1975 Nov; 12(5):1029-36. PubMed ID: 172450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
